Scienture Holdings Files 8-K with Bylaw Amendments
Ticker: SCNX · Form: 8-K · Filed: Sep 24, 2024 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Scienture Holdings, Inc. (SCNX) |
| Form Type | 8-K |
| Filed Date | Sep 24, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, bylaws
TL;DR
Scienture Holdings (formerly TRxADE HEALTH) filed an 8-K on 9/24 for events on 9/20, including bylaw changes.
AI Summary
Scienture Holdings, Inc. filed an 8-K on September 24, 2024, reporting events as of September 20, 2024. The filing indicates amendments to articles of incorporation or bylaws, a Regulation FD disclosure, and financial statements and exhibits. The company was formerly known as TRxADE HEALTH, INC. and is incorporated in Delaware.
Why It Matters
This 8-K filing signals potential changes in Scienture Holdings' corporate governance or operational structure, which could impact its business strategy and investor relations.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure and does not immediately indicate significant financial distress or operational disruption.
Key Players & Entities
- Scienture Holdings, Inc. (company) — Registrant
- September 20, 2024 (date) — Earliest event reported
- September 24, 2024 (date) — Filing date
- TRxADE HEALTH, INC. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific amendments were made to Scienture Holdings' articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What is the nature of the Regulation FD disclosure included in this filing?
The provided text does not specify the content of the Regulation FD disclosure, only that it is part of the filing.
When was Scienture Holdings, Inc. previously known as TRxADE HEALTH, INC.?
The date of the name change from TRxADE HEALTH, INC. to Scienture Holdings, Inc. was June 2, 2021.
What is the primary business of Scienture Holdings, Inc. according to its SIC code?
Scienture Holdings, Inc. is classified under SIC code 5122, which pertains to the wholesale of drugs, proprietaries, and druggists' sundries.
What is the fiscal year end for Scienture Holdings, Inc.?
The fiscal year end for Scienture Holdings, Inc. is December 31.
Filing Stats: 733 words · 3 min read · ~2 pages · Grade level 9.1 · Accepted 2024-09-24 16:05:38
Key Financial Figures
- $0.00001 — ch registered Common stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex3-1.htm (EX-3.1) — 2KB
- ex99-1.htm (EX-99.1) — 13KB
- ex3-1_001.jpg (GRAPHIC) — 143KB
- ex3-1_002.jpg (GRAPHIC) — 310KB
- ex99-1_001.jpg (GRAPHIC) — 13KB
- ex99-2.htm (EX-99.2) — 17KB
- ex99-2_001.jpg (GRAPHIC) — 14KB
- 0001493152-24-037953.txt ( ) — 925KB
- meds-20240920.xsd (EX-101.SCH) — 3KB
- meds-20240920_lab.xml (EX-101.LAB) — 34KB
- meds-20240920_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer Date: September 24, 2024